Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study
dc.authorid | Sonmez, Alper/0000-0002-9309-7715 | |
dc.authorid | Birinci, Suayip/0000-0001-8104-6198 | |
dc.authorid | Dagdelen, Selcuk/0000-0002-0513-1750 | |
dc.authorid | sahin, mustafa/0000-0002-4718-0083 | |
dc.authorid | Satman, Ilhan/0000-0001-8613-1797 | |
dc.authorid | Demirci, Ibrahim/0000-0003-0498-3115 | |
dc.authorid | TASCI, ILKER/0000-0002-0936-2476 | |
dc.authorwosid | Sonmez, Alper/H-8588-2019 | |
dc.authorwosid | Birinci, Suayip/JFJ-4049-2023 | |
dc.authorwosid | Dagdelen, Selcuk/A-9432-2017 | |
dc.authorwosid | sahin, mustafa/AAH-3394-2019 | |
dc.authorwosid | Celik, Osman/KLZ-6766-2024 | |
dc.authorwosid | Ustun, Yaprak/KFQ-9767-2024 | |
dc.authorwosid | Satman, Ilhan/AAS-7044-2020 | |
dc.contributor.author | Demirci, Ibrahim | |
dc.contributor.author | Haymana, Cem | |
dc.contributor.author | Tasci, Ilker | |
dc.contributor.author | Satman, Ilhan | |
dc.contributor.author | Atmaca, Aysegul | |
dc.contributor.author | Sahin, Mustafa | |
dc.contributor.author | Ata, Naim | |
dc.date.accessioned | 2024-08-04T20:51:42Z | |
dc.date.available | 2024-08-04T20:51:42Z | |
dc.date.issued | 2022 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Introduction: COVID-19 disease has a worse prognosis in patients with diabetes, but comparative data about the course of COVID-19 in patients with type 1 (T1DM) and type 2 diabetes (T2DM) are lacking. The purpose of this study was to find out the relative clinical severity and mortality of COVID-19 patients with T1DM and T2DM. Material and methods: A nationwide retrospective cohort of patients with confirmed (PCR positive) COVID-19 infection (n = 149,671) was investigated. After exclusion of individuals with unspecified diabetes status, the adverse outcomes between patients with T1DM (n = 163), T2DM (n = 33,478) and those without diabetes (n = 115,108) were compared by using the propensity score matching method. The outcomes were hospitalization, the composite of intensive care unit (ICU) admission and/or mechanical ventilation, and mortality. Results: The patients with T1DM had higher mortality than the age- and gender-matched patients with T2DM (n = 489) and those without diabetes (n = 489) (p < 0.001). After further adjustment for the HbA(1c), and microvascular and macrovascular complications, the odds of mortality (OR: 3.35, 95% CI: 1.41-7.96, p = 0.006) and ICU admission and/or mechanical ventilation (OR: 2.95, 95% CI: 1.28-6.77, p = 0.011) were significantly higher in patients with T1DM compared to those with T2DM. Older age (OR: 1.06, 95% CI: 1.01-1.12, p = 0.028) and lymphopaenia (OR: 5.13, 95% CI: 1.04-25.5, p = 0.045) were independently associated with mortality in patients with T1DM. Conclusions: Patients with T1DM had worse prognosis of COVID-19 compared to T2DM patients or those without diabetes. These cases should be cared for diligently until more data become available about the causes of increased COVID-19 mortality in T1DM. | en_US |
dc.identifier.doi | 10.5603/EP.a2022.0008 | |
dc.identifier.endpage | 95 | en_US |
dc.identifier.issn | 0423-104X | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 35119089 | en_US |
dc.identifier.scopus | 2-s2.0-85124979113 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 87 | en_US |
dc.identifier.uri | https://doi.org/10.5603/EP.a2022.0008 | |
dc.identifier.uri | https://hdl.handle.net/11616/100495 | |
dc.identifier.volume | 73 | en_US |
dc.identifier.wos | WOS:000804688900012 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Via Medica | en_US |
dc.relation.ispartof | Endokrynologia Polska | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | coronavirus | en_US |
dc.subject | type 1 diabetes | en_US |
dc.subject | mortality | en_US |
dc.subject | diabetes mellitus | en_US |
dc.subject | T1DM | en_US |
dc.subject | Turkey | en_US |
dc.title | Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide study | en_US |
dc.type | Article | en_US |